These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21129964)

  • 21. Glucocorticoid receptor antagonists.
    Clark RD
    Curr Top Med Chem; 2008; 8(9):813-38. PubMed ID: 18537690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
    McMaster A; Ray DW
    Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Cai H; Connolly PJ; Peng S; Stauber K; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6123-8. PubMed ID: 17904840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists.
    Baker J; Bingham M; Blackburn-Munro R; Cai J; Craighead M; Gilfillan R; Goan K; Jaap D; Milne R; Morphy JR; Napier S; Presland J; Spinks G; Thomson F
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3603-7. PubMed ID: 21601454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of orally available tetrahydroquinoline-based glucocorticoid receptor agonists.
    Hudson AR; Higuchi RI; Roach SL; Adams ME; Vassar A; Syka PM; Mais DE; Miner JN; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1697-700. PubMed ID: 21316964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site.
    Luz JG; Carson MW; Condon B; Clawson D; Pustilnik A; Kohlman DT; Barr RJ; Bean JS; Dill MJ; Sindelar DK; Maletic M; Coghlan MJ
    J Med Chem; 2015 Aug; 58(16):6607-18. PubMed ID: 26218343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.
    Corbett DF; Heightman TD; Moss SF; Bromidge SM; Coggon SA; Longley MJ; Roa AM; Williams JA; Thomas DR
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4014-8. PubMed ID: 16002289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear receptor drug discovery.
    Chen T
    Curr Opin Chem Biol; 2008 Aug; 12(4):418-26. PubMed ID: 18662801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The characterization of a novel V1b antagonist lead series.
    Smethurst CA; Borthwick JA; Gaines S; Watson S; Green A; Schulz MJ; Burton G; Buson AA; Arban R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):92-6. PubMed ID: 21146408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.
    Witherington J; Abberley L; Briggs MA; Collis K; Dean DK; Gaiba A; King NP; Kraus H; Shuker N; Steadman JG; Takle AK; Sanger G; Wadsworth G; Butler S; McKay F; Muir A; Winborn K; Heightman TD
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2203-5. PubMed ID: 18316188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
    Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
    Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and SAR study of novel dihydroquinoline containing glucocorticoid receptor ligands.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1549-52. PubMed ID: 16386422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.
    Allison BD; Phuong VK; McAtee LC; Rosen M; Morton M; Prendergast C; Barrett T; Lagaud G; Freedman J; Li L; Wu X; Venkatesan H; Pippel M; Woods C; Rizzolio MC; Hack M; Hoey K; Deng X; King C; Shankley NP; Rabinowitz MH
    J Med Chem; 2006 Oct; 49(21):6371-90. PubMed ID: 17034143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV; Deshpande AD; Kambhampati R; Badange RK; Kota L; Daulatabad AV; Shinde AK; Ahmad I; Kandikere V; Jayarajan P; Dubey PK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):346-9. PubMed ID: 21134749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug insight: selective agonists and antagonists of the glucocorticoid receptor.
    McMaster A; Ray DW
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):91-101. PubMed ID: 18212811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of new spirocyclic muscarinic M3 antagonists.
    Stocks MJ; Alcaraz L; Bailey A; Bowers K; Donald D; Edwards H; Hunt F; Kindon N; Pairaudeau G; Theaker J; Warner DJ
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7458-61. PubMed ID: 21036043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.
    Takahashi H; Bekkali Y; Capolino AJ; Gilmore T; Goldrick SE; Kaplita PV; Liu L; Nelson RM; Terenzio D; Wang J; Zuvela-Jelaska L; Proudfoot J; Nabozny G; Thomson D
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5091-5. PubMed ID: 17681466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators.
    Link JT; Sorensen B; Patel J; Grynfarb M; Goos-Nilsson A; Wang J; Fung S; Wilcox D; Zinker B; Nguyen P; Hickman B; Schmidt JM; Swanson S; Tian Z; Reisch TJ; Rotert G; Du J; Lane B; von Geldern TW; Jacobson PB
    J Med Chem; 2005 Aug; 48(16):5295-304. PubMed ID: 16078847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion.
    Peeters BW; Tonnaer JA; Groen MB; Broekkamp CL; van der Voort HA; Schoonen WG; Smets RJ; Vanderheyden PM; Gebhard R; Ruigt GS
    Stress; 2004 Dec; 7(4):233-41. PubMed ID: 16019588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2.
    D'Alessandro PL; Corti C; Roth A; Ugolini A; Sava A; Montanari D; Bianchi F; Garland SL; Powney B; Koppe EL; Rocheville M; Osborne G; Perez P; de la Fuente J; De Los Frailes M; Smith PW; Branch C; Nash D; Watson SP
    Bioorg Med Chem Lett; 2010 Jan; 20(2):759-62. PubMed ID: 20005096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.